ELECTROMEDICAL TECHNOLOGIES, INC. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings
ELECTROMEDICAL TECHNOLOGIES, INC. (EMED) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings of $677.63 thousand for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-19.
Financial Statements › Income Statement › Other Income
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings · last filed 2024-11-19
- ELECTROMEDICAL TECHNOLOGIES, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2024-09-30 was $338.70K.
- ELECTROMEDICAL TECHNOLOGIES, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2024-06-30 was -$337.44K.
- ELECTROMEDICAL TECHNOLOGIES, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2024-03-31 was $676.37K.
- ELECTROMEDICAL TECHNOLOGIES, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2023-12-31 was $56.72K.
- ELECTROMEDICAL TECHNOLOGIES, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for fiscal 2023 was $120.61K.
- ELECTROMEDICAL TECHNOLOGIES, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for fiscal 2021 was $1.42M.
- ELECTROMEDICAL TECHNOLOGIES, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for fiscal 2020 was -$63.63K, a 404.47% decline from fiscal 2019.
- ELECTROMEDICAL TECHNOLOGIES, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for fiscal 2019 was $20.90K.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 9 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 12 month |
|---|---|---|---|---|
| 2024-09-30 | $338.70K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-19 | $1.26K derived: sum of 2 quarters · filed 2024-11-19 | $677.63K 10-Q · filed 2024-11-19 | $734.35K derived: sum of 4 quarters · filed 2024-11-19 |
| 2024-06-30 | -$337.44K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $338.94K 10-Q · filed 2024-08-14 | $395.66K derived: sum of 3 quarters · filed 2024-08-14 | $332.59K derived: sum of 4 quarters · filed 2024-08-14 |
| 2024-03-31 | $676.37K 10-Q · filed 2024-06-14 | $733.10K derived: sum of 2 quarters · filed 2024-06-14 | $670.03K derived: sum of 3 quarters · filed 2024-06-14 | |
| 2023-12-31 | $56.72K derived: 10-K 12 month − 10-Q 9 month · filed 2024-05-01 | -$6.35K derived: sum of 2 quarters · filed 2024-05-01 | $120.61K 10-K · filed 2024-05-01 | |
| 2023-09-30 | -$63.07K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-20 | $63.89K 10-Q · filed 2023-11-20 | ||
| 2023-06-30 | $126.96K 10-Q · filed 2023-08-21 | |||
| 2021-12-31 | -$21.07K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $1.95M derived: sum of 2 quarters · filed 2023-03-31 | $1.43M derived: sum of 3 quarters · filed 2023-03-31 | $1.42M 10-K · filed 2023-03-31 |
| 2021-09-30 | $1.97M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2021-11-15 | $1.45M derived: sum of 2 quarters · filed 2021-11-15 | $1.44M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | -$522.61K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2021-09-03 | -$537.41K 10-Q/A · filed 2021-09-03 | ||
| 2021-03-31 | -$14.80K 10-Q · filed 2021-05-14 | |||
| 2020-12-31 | -$63.63K 10-K · filed 2022-03-31 | |||
| 2019-12-31 | $20.90K 10-K · filed 2021-03-30 |